# Shenzhen Gatecore Biotech Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shenzhen-gatecore-biotech-co

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Latest round: Series A (Dec 8, 2025)
- Investors on record: 3

## About

Based in Shenzhen, China and founded in 2023, Shenzhen Gatecore Biotech Co., Ltd., develops semiconductor-enabled proteomics detection technologies for the biotechnology and medical research sectors. The company was established at the intersection of biology and semiconductors to address unmet needs in ultra-sensitive protein analysis and scalable immunodetection. The company works with research institutions, biotech firms, and diagnostics developers to provide ultra-sensitive single-molecule immunodetection platforms and related proteomics technologies. Its semiconductor-driven systems enable fast, high-throughput, and low-cost protein detection for applications such as early disease screening, biomarker discovery, and precision diagnostics. The company generates revenue by supplying its detection platforms and associated technology solutions to research, diagnostics, and biotech customers.
In December 2025, Shenzhen Gatecore Biotech Co., Ltd. closed Series A funding from new investors Shenzhen Capital Real Estate Fund, Shenzhen Nanshan Huirong Investment and Taiyou Fund.

## Funding rounds

- Series A, Dec 8, 2025 — Taiyou Fund, Shenzhen Capital Real Estate Fund, Shenzhen Nanshan Huirong Investment

## Investors

- Taiyou Fund — Series A
- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series A
- Shenzhen Nanshan Huirong Investment — Series A